Why Encompass Health (EHC) is a Top Value Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why You Should Add Encompass Health (EHC) to Your Portfolio Now
Encompass Health (EHC) remains well-poised for growth on the back of robust demand for effective inpatient rehabilitation services, joint ventures and solid cash reserves.
Encompass Health Corporation (EHC) Hits Fresh High: Is There Still Room to Run?
Encompass Health (EHC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Encompass Health to present at BofA Securities 2024 Health Care Conference
BIRMINGHAM, Ala. , May 6, 2024 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced it will participate in the BofA Securities 2024 Health Care Conference being held in Las Vegas May ...
4 Safe Bets Amid Growing Concerns Over Delay in Rate Cuts
Investing in defensive stocks like ResMed Inc. (RMD), Encompass Health Corporation (EHC), New Jersey Resources Corporation (NJR) and Global Water Resources, Inc. (GWRS) would be a wise idea during ...
EHC or CHE: Which Is the Better Value Stock Right Now?
Investors looking for stocks in the Medical - Outpatient and Home Healthcare sector might want to consider either Encompass Health (EHC) or Chemed (CHE). But which of these two stocks offers value ...
Encompass Health (EHC) Stock Down Despite Q1 Earnings Beat
Encompass Health (EHC) increases its guidance for net operating revenues, which is in the range of $5.25-$5.325 million for 2024.
Why Encompass Health (EHC) is a Top Momentum Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Encompass Health Corporation (EHC) Hit a 52 Week High, Can the Run Continue?
Encompass Health (EHC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Here's What Key Metrics Tell Us About Encompass Health (EHC) Q1 Earnings
The headline numbers for Encompass Health (EHC) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Stre...
Insights Into Encompass Health (EHC) Q1: Wall Street Projections for Key Metrics
Evaluate the expected performance of Encompass Health (EHC) for the quarter ended March 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key...
Should You Buy Encompass Health (EHC) Ahead of Q1 Earnings?
Encompass Health's (EHC) Q1 results are likely to benefit on the back of growing patient volumes and commendable expansion initiatives.
Encompass Health (EHC) Plans a 50-Bed Facility to Serve Texas
Encompass Health (EHC) unveils plans to build an inpatient rehabilitation hospital in San Antonio to bring improved health outcomes and further fortify its presence in Texas.
Why Encompass Health (EHC) is a Top Growth Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Encompass Health (EHC) Up 42% in a Year: What Lies Ahead?
Encompass Health (EHC) remains well-poised for growth on the back of sustained top-line growth, an expanding healthcare facility portfolio and robust cash-generating abilities.
Related Companies